Announce Date | 02/14/2025 |
EPS Normalized Actual | $0 (Beat by $0.06) |
EPS GAAP Actual | $0 (Beat by $0.06) |
Revenue Actual | $1.3808B |
Revenue Surprise | Beat by $1380.8M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.10488 |
EPS GAAP Estimate | $0.10488 |
Revenue Estimate | $1.565335892B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 1.5689 | 2.05 | 1.52537 | 1.61683 | 1 |
Dec 2028 | 1.0668 | 3.02 | 1.0372 | 1.09939 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.12 | -0.12 | 1.3808B | -5.95% | 1380.8M |
FQ3 2024 (Sep 2024) | 0.08 | 0.08 | 1.5049B | -3.12% | 1504.9M |
FQ2 2024 (Jun 2024) | 0.15 | 0.15 | 1.6323B | 3.77% | 1632.3M |
FQ1 2024 (Mar 2024) | 0.17 | 0.17 | 1.6069B | 7.03% | 1606.9M |
FQ4 2023 (Dec 2023) | -0.17 | -0.17 | 1.463B | 4.81% | 1463M |
FQ3 2023 (Sep 2023) | -0.15 | -0.15 | 1.5519B | 1.08% | 1551.9M |
FQ2 2023 (Jun 2023) | 0.07 | 0.07 | 1.5707B | 8.43% | 1570.7M |
FQ1 2023 (Mar 2023) | -0.0885 | -0.0885 | 1.4939B | 100% | 1493.9M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.10488
Consensus Revenue Estimates
1.565335892B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.22 | -- | 0.21599 | 0.22482 | 1 |
FQ2 2027 (Jun 2027) | 0.18 | -- | 0.17672 | 0.18394 | 1 |
FQ1 2027 (Mar 2027) | -0.04 | -- | -0.04087611 | -0.0392706 | 1 |
FQ4 2026 (Oct 2026) | 0.37 | -- | 0.35384 | 0.37975 | 3 |
FQ3 2026 (Jul 2026) | 0.26 | -- | 0.24865 | 0.26685 | 4 |
FQ2 2026 (Jun 2026) | 0.23 | -- | 0.22115 | 0.23581 | 3 |
FQ1 2026 (Mar 2026) | 0.02 | -- | 0.01923062 | 0.02050483 | 3 |
FQ4 2025 (Oct 2025) | 0.16014 | 174.93 | 0.15315 | 0.16436 | 3 |
FQ3 2025 (Jul 2025) | 0.12652 | 36.77 | 0.121 | 0.12985 | 3 |
FQ2 2025 (Jun 2025) | 0.10488 | -43.02 | 0.10085 | 0.10753 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.48B | -- | 1.46B | 1.51B | 2 |
FQ2 2027 (Jun 2027) | 1.51B | -- | 1.49B | 1.53B | 2 |
FQ1 2027 (Mar 2027) | 1.39B | -- | 1.37B | 1.41B | 2 |
FQ4 2026 (Oct 2026) | 1.63B | -- | 1.58B | 1.66B | 4 |
FQ3 2026 (Jul 2026) | 1.56B | -- | 1.51B | 1.59B | 4 |
FQ2 2026 (Jun 2026) | 1.56B | -- | 1.52B | 1.59B | 2 |
FQ1 2026 (Mar 2026) | 1.5B | -- | 1.46B | 1.53B | 2 |
FQ4 2025 (Oct 2025) | 1.6B | 13.49 | 1.54B | 1.63B | 2 |
FQ3 2025 (Jul 2025) | 1.56B | 3.69 | 1.51B | 1.59B | 2 |
FQ2 2025 (Jun 2025) | 1.57B | -4.28 | 1.52B | 1.6B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.12 | -0.12 | 100% | |
FQ3 2024 (Sep 2024) | 0.08 | 0.08 | 100% | |
FQ2 2024 (Jun 2024) | 0.15 | 0.15 | 100% | |
FQ1 2024 (Mar 2024) | 0.17 | 0.17 | 100% | |
FQ4 2023 (Dec 2023) | -0.17 | -0.17 | 100% | |
FQ3 2023 (Sep 2023) | -0.15 | -0.15 | 100% | |
FQ2 2023 (Jun 2023) | 0.07 | 0.07 | 100% | |
FQ1 2023 (Mar 2023) | -0.0885 | -0.0885 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $1.38B | $1380.8M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.5B | $1504.9M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.63B | $1632.3M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.61B | $1606.9M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.46B | $1463M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.55B | $1551.9M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.57B | $1570.7M | 100% |
FQ1 2023 (Mar 2023) | $0B | $1.49B | $1493.9M | 100% |